Should I Buy NUS? NUS 2026 Analysis

Should You Buy NU Skin Enterprises Inc (NUS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

10.640

1 Day change

5.35%

52 Week Range

14.620

Analysis Updated At

2026/01/26

Nu Skin Enterprises Inc (NUS) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown improvement in net income and EPS, the significant revenue decline and lack of strong positive catalysts make it prudent to hold off on investing until further clarity or improvement in fundamentals emerges.

Technical Analysis

The technical indicators suggest a neutral to slightly bullish trend. The MACD is positive but contracting, RSI is neutral, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at 11.508 and 11.879, with support at 10.309 and 9.938. However, the stock's short-term trend indicates a likelihood of minor declines in the next day (-0.94%) and week (-1.47%), with a modest potential gain (1.37%) in the next month.

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

The company's net income increased by 105.72% YoY, EPS grew by 100.00% YoY, and gross margin improved slightly to 70.49%. These financial improvements could signal better operational efficiency.

Neutral/Negative Catalysts

Revenue dropped significantly by 15.33% YoY in Q3 2025, which raises concerns about the company's ability to grow its top line. Additionally, there is no recent insider or hedge fund activity indicating strong confidence in the stock. Options data shows a high put-call volume ratio, suggesting bearish sentiment among traders.

Financial Performance

In Q3 2025, revenue dropped to $364.21M (-15.33% YoY), but net income increased to $17.08M (+105.72% YoY). EPS rose to 0.34 (+100.00% YoY), and gross margin improved slightly to 70.49% (+0.59% YoY). This indicates profitability improvements despite revenue challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes are available for NUS. Wall Street sentiment appears neutral, with no significant pros or cons highlighted.

Analyst Rating

Wall Street analysts forecast NUS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NUS is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy